For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.
The Office of Sponsored Research Administration is closely tracking guidance issued by the NIH, DOD and other grant making agencies with regard to COVID-19. See below for the most recent updates. For WCM's COVID-19 Guidance page, visit WCM Central.
Guidance for WCM Investigators conducting scientific and animal research related to COVID-19 can be found here.
NIH COVID-19 Administrative Supplement and Competitive Revision opportunities: COVID-19 Opportunities
Administrative Supplement and Competitive Revision information and side by side comparison table: Information Table
Administrative Supplement and Competitive Revision application checklist: Checklist
NIH & WCM Award Management Flexibilities: Flexibilities Chart
In light of the COVID-19 pandemic, the NIH recently revised the requirements for preliminary data post-submission requirements for researchers preparing grant applications for the January 2021 council (Cycle II deadlines, beginning with applications submitted for the May 25, 2020 due date). NIH will accept a one-page update with preliminary data as post-submission materials for applications submitted under all activity codes, only if the Funding Opportunity Announcement used for submission allowed preliminary data in the application. One page of preliminary data will be accepted for single component applications or for each component of a multi-component application.
The Council on Governmental Relations (COGR), a national association of research institutions, has assembled extensive FAQs on federal agency guidance regarding the response to COVID-19.
Due to the recent COVID-19 outbreak the application due dates for the New York State Stem Cell Investigator Initiated Research Projects (IIRP) and Innovative, Developmental or Exploratory Activities (IDEA) are being extended to June 25, 2020 at 4pm.
A comprehensive list of NIH opportunities is available here.
The National Science Foundation (NSF) is accepting proposals to conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate about the science of virus transmission and prevention, and to encourage the development of processes and actions to address this global challenge.
NSF encourages the research community to respond to this challenge through existing funding opportunities.
More information is available here.
The Department of Defense requests enhanced white papers for the Development of Treatments for COVID-19. Deadline is April 8th.
NIH's comprehensive COVID-19 overview page can be found here.
Updated, robust guidance for DOD Awardees can be found on their comprehensive website here.
NIH further revised their late submission policy during the COVID-19 crisis NOT-OD-20-091
NIH understands that the emergency declaration related to novel coronavirus (COVID-19) will adversely affect many NIH applicants' ability to submit applications in a timely manner.
Therefore, all grant applications submitted late for due dates between March 9, 2020, and May 1, 2020, will be accepted through May 1, 2020.
Due to impacts of COVID-19, the DOD has extended some application due dates, see table below.
Requests for further extensions to the new deadlines will not be accepted. Please consult the modified Program Announcements.
Program | Deadline Type | New Deadline Date |
Breast Cancer Research Program Breakthrough Award Levels 1 and 2 | Full Application | March 30th, 2020 |
Breast Cancer Research Program Era of Hope Scholar Award | Full Application | March 30th, 2020 |
| Amyotrophic Lateral Sclerosis Research Program | Pre-application | April 15th, 2020 |
| Autism Research Program | Pre-application | April 28th, 2020 |
| Ovarian Cancer Research Program | Pre-application | April 30th, 2020 |
NIH outlines administrative flexibilities applicable to NIH applicants and recipients where the entity is conducting research activities related to or affected by COVID-19. Affected entities are those that have been closed, or business activities have been hindered due to COVID-19 precautionary measures and/or illness. Affected entities will be asked to provide documentation to NIH describing effects.
Full Announcement: NOT-OD-20-086
